loader image
Sunday, November 23, 2025
79.2 F
McAllen
- Advertisement -

DHR Health Welcomes Interventional Cardiologist, Dr. Khaled Ali B. Sherif

Translate to Spanish or other 102 languages!

Dr. Khaled Ali B. Sherif
- Advertisement -

Edinburg, TX: DHR Health is honored to welcome Dr. Khaled Ali B. Sherif, a highly accomplished, triple board-certified interventional cardiologist, to our renowned cardiology team at the DHR Health Heart Institute. Dr. Sherif’s extensive training and expertise in internal medicine, geriatric medicine, and cardiovascular disease, along with his advanced specialization in interventional cardiology and structural heart disease, will be an incredible asset to our team. His arrival strengthens DHR Health’s commitment to exceptional heart care for our community.

“It is with great honor that we welcome back Dr. Sherif to the DHR Health Family,” said Marissa Castaneda, Executive Vice President at DHR Health. “With his skills and expertise, his addition to our team will greatly enhance our mission to improve the well-being of those we serve with a commitment to excellence.”

Dr. Sherif began his medical career driven by a deep dedication to understanding the complexities of heart health, particularly in managing heart failure and advancing diagnostic methods. After earning his medical degree from the University of Tripoli Faculty of Medicine in Libya, he completed two internal medicine residency programs—one at Texas Tech University Health Sciences Center in Lubbock, Texas, and the other at Tripoli Central Hospital in Libya. He then pursued advanced training in the U.S., including an interventional cardiology and structural heart disease fellowship at HCA Medical City Fort Worth and a cardiology fellowship with The University of Texas Rio Grande Valley at DHR Health. He also received specialized training in advanced heart failure, geriatric medicine, and palliative medicine, making him exceptionally well-rounded in his field.

- Advertisement -

Known for his compassionate, patient-centered approach, Dr. Sherif is committed to tailoring treatment plans to each patient’s unique needs. He shares, “I love to connect with my patients and their families. I found cardiology to be the specialty that fulfills this feeling. It is the specialty that makes humble as I learn new things every day from the field and from my patients.” Dr. Sherif is also deeply invested in advancing cardiology through ongoing research, with his findings shared in publications and at conferences nationwide.

Dr. Sherif is excited to provide high-quality cardiovascular care to the Rio Grande Valley. He is now seeing new patients at his office located at 1200 E. Savannah, Suite 21 in McAllen. To make an appointment, call (956) 362-8400. DHR Health accepts most medical insurance, including Medicare and Medicaid.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Current Heart Attack Screening Tools Are Not Optimal and Fail to Identify Half the People Who Are at Risk

Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at risk of having one, according to a new study led by Mount Sinai researchers.

Don’t Overfill Your Plate or Stomach

We’ve all been there: You’re gathered with family or friends for a delicious holiday meal. You start piling food on your plate, and before you know it, there’s no room left – and you haven’t even made it to the cranberry sauce and sweet potatoes.

UT Health San Antonio Center For Brain Health Celebrates with Ribbon Cutting

University of Texas System and UT San Antonio leaders today hailed “a new era of hope, healing and discovery” for neurological patients and their families with a ribbon-cutting for the UT Health San Antonio Center for Brain Health, a $100 million, 103,000-square-foot facility that will bring specialty care, therapy, diagnostics and research under one ro

Rare Mutation that Predicts Strong Immunotherapy Response in Colorectal Cancer Identified

A new study led by researchers at The University of Texas MD Anderson Cancer Center shows that a specific subset of mutations in the POLE gene is strongly associated with durable responses to immunotherapy in patients with metastatic colorectal cancer (CRC).
- Advertisement -
×